P&K Skin Research Center Co., Ltd. (KOSDAQ:347740)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,415.00
-55.00 (-2.23%)
At close: Dec 5, 2025

P&K Skin Research Center Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22
Net Income
6,6475,8164,8137,130
Depreciation & Amortization
1,9961,8481,7351,468
Loss (Gain) From Sale of Assets
0.990.3100.97
Loss (Gain) From Sale of Investments
-936.67-712.69-140.01185.18
Stock-Based Compensation
-15.8465.7165.98
Provision & Write-off of Bad Debts
2.3461.7280.7348.15
Other Operating Activities
-483.33682.78-1,263-439.34
Change in Accounts Receivable
245.76236.27146.84-753.86
Change in Other Net Operating Assets
-260.431,083110.94-198.24
Operating Cash Flow
7,2119,0325,5497,507
Operating Cash Flow Growth
-19.95%62.77%-26.08%-
Capital Expenditures
-1,764-622.12-1,526-1,230
Sale (Purchase) of Intangibles
---33.34-126.01
Investment in Securities
-7,168-8,1026,468-2,457
Other Investing Activities
29.83--786.62-406.26
Investing Cash Flow
-8,901-8,874972.22-4,320
Long-Term Debt Repaid
--394.27-372.54-318.02
Net Debt Issued (Repaid)
-447.34-394.27-372.54-318.02
Issuance of Common Stock
---1,495
Repurchase of Common Stock
--2,386-610.61-
Dividends Paid
-976.98-714.68-872.08-892.93
Other Financing Activities
--149-0
Financing Cash Flow
-1,424-3,495-1,706283.73
Foreign Exchange Rate Adjustments
0.480.520.010.03
Net Cash Flow
-3,113-3,3364,8153,471
Free Cash Flow
5,4478,4104,0236,277
Free Cash Flow Growth
-34.65%109.06%-35.91%-
Free Cash Flow Margin
24.62%47.12%27.10%34.96%
Free Cash Flow Per Share
188.61289.65134.13210.50
Cash Interest Paid
30.9724.3430.4823.93
Cash Income Tax Paid
1,542681.741,3291,178
Levered Free Cash Flow
2,3933,915-2,996-
Unlevered Free Cash Flow
2,4213,931-2,976-
Change in Working Capital
-14.671,319257.78-952.1
Source: S&P Capital IQ. Standard template. Financial Sources.